SCANDONEST

This brand name is authorized in Croatia, Ecuador, Estonia, Finland, France, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, Spain, UK.

Active ingredients

The drug SCANDONEST contains one active pharmaceutical ingredient (API):

1	Mepivacaine UNII 4VFX2L7EM5 - MEPIVACAINE HYDROCHLORIDE
	Mepivacaine is an amide local anaesthetic. Mepivacaine has a rapid onset, a high potency of anaesthesia and a low toxicity.
	Read more about Mepivacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SCANDONEST 3% PLAIN Solution for injection	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB03	Mepivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	23.185-1-09-07, 25.579-02-04
EE	Ravimiamet	1010956, 1787542
ES	Centro de información online de medicamentos de la AEMPS	69095
FI	Lääkealan turvallisuus- ja kehittämiskeskus	105142
FR	Base de données publique des médicaments	66701169
GB	Medicines & Healthcare Products Regulatory Agency	52448
HR	Agencija za lijekove i medicinske proizvode	HR-H-750439888
LT	Valstybinė vaistų kontrolės tarnyba	1087017, 1087018
MT	Medicines Authority	MA035/00401
NL	Z-Index G-Standaard	14213699
NL	Z-Index G-Standaard, PRK	66850
NZ	Medicines and Medical Devices Safety Authority	2920
PL	Rejestru Produktów Leczniczych	100060223
SG	Health Sciences Authority	07075P